<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0374630</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3841</journal-id>
<journal-id journal-id-type="nlm-ta">Gastroenterology</journal-id>
<journal-id journal-id-type="iso-abbrev">Gastroenterology</journal-id>
<journal-title-group>
<journal-title>Gastroenterology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0016-5085</issn>
<issn pub-type="epub">1528-0012</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31220424</article-id>
<article-id pub-id-type="pmc">7179251</article-id>
<article-id pub-id-type="doi">10.1053/j.gastro.2019.04.053</article-id>
<article-id pub-id-type="manuscript">NIHMS1532088</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fecal Microbial Transplantation For Diseases Beyond Recurrent <italic>Clostridium Difficile</italic> Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dâ€™Haens</surname>
<given-names>Geert R.</given-names>
</name>
<aff id="A1">Dept of Gastroenterology, Amsterdam University Medical Center, Meibergdreef 9, 1100 DZ Amsterdam, The Netherlands</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jobin</surname>
<given-names>Christian</given-names>
</name>
<aff id="A2">Dept of Medicine, Dept of Anatomy and Cell Biology, Dept of Infectious Diseases and Immunology, University of Florida, 2033 Mowry Rd, PO Box 103633, Gainesville, FL, USA</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="CR1">Correspondence: Christian Jobin, <email>Christian.Jobin@medicine.ufl.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2020</year>
</pub-date>
<volume>157</volume>
<issue>3</issue>
<fpage>624</fpage>
<lpage>636</lpage>
<!--elocation-id from pubmed: 10.1053/j.gastro.2019.04.053-->
<abstract id="ABS1">
<p id="P1">As microbiome research has moved from associative to mechanistic studies, the activities of specific microbes and their products have been investigated in development of inflammatory bowel diseases, cancer, metabolic syndrome, and neuropsychiatric disorders. Findings from microbiome research have already been applied to the clinic, such as in fecal microbiota transplantation (FMT) for treatment of recurrent <italic>Clostridium difficile</italic> infection. We review the evidence for associations between alterations in the intestinal microbiome and gastrointestinal diseases and findings from clinical trials of FMT. We discuss opportunities for treatment of other diseases with FMT, based on findings from small clinical and preclinical studies.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>